HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Involvement of the YIGSR sequence of laminin in protein tyrosine phosphorylation.

Abstract
We have examined the mechanism of signaling by the 67 kDa YIGSR binding protein of laminin and its properties in neuroblastoma cells. Ligand displacement analysis showed that the interaction with the C(YIGSR)3-NH2 peptide amide is of intermediate affinity (1.5 x 10[-7] M). Cross-linking experiments with sulfo-MBS detected an additional protein with a molecular mass of 116 kDa that binds the YIGSR sequence. Incubation of neuroblastoma cells with C(YIGSR)3-NH2 peptide amide or antibody directed against the 67 kDa laminin binding protein induces tyrosine phosphorylation of proteins with a molecular mass ranging from 115 to 130 kDa and another heterogeneous protein group of 32 kDa.
AuthorsI Bushkin-Harav, U Z Littauer
JournalFEBS letters (FEBS Lett) Vol. 424 Issue 3 Pg. 243-7 (Mar 13 1998) ISSN: 0014-5793 [Print] England
PMID9539159 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies
  • Cross-Linking Reagents
  • Laminin
  • Peptide Fragments
  • Protein Precursors
  • Proteins
  • Receptors, Laminin
  • Tyrosine
  • Type C Phospholipases
  • Phosphatidylinositol Diacylglycerol-Lyase
Topics
  • Amino Acid Sequence
  • Animals
  • Antibodies (metabolism, pharmacology)
  • Binding Sites
  • Cross-Linking Reagents
  • Humans
  • Laminin (metabolism)
  • Mice
  • Molecular Sequence Data
  • Neuroblastoma (metabolism)
  • Peptide Fragments (pharmacology)
  • Phosphatidylinositol Diacylglycerol-Lyase
  • Phosphorylation (drug effects)
  • Protein Precursors
  • Proteins (chemistry, metabolism)
  • Rats
  • Receptors, Laminin (drug effects, immunology, metabolism)
  • Signal Transduction
  • Tumor Cells, Cultured
  • Type C Phospholipases (pharmacology)
  • Tyrosine (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: